BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29264579)

  • 41. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
    Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
    J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
    Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y
    Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.
    He N; Park K; Zhang Y; Huang J; Lu S; Wang L
    Gastroenterology; 2008 Mar; 134(3):793-802. PubMed ID: 18325392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
    Oya H; Kanda M; Sugimoto H; Shimizu D; Takami H; Hibino S; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Gastroenterol; 2015 May; 50(5):590-600. PubMed ID: 25173447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cysteine dioxygenase type 1 promotes adipogenesis via interaction with peroxisome proliferator-activated receptor gamma.
    Deng P; Chen Y; Ji N; Lin Y; Yuan Q; Ye L; Chen Q
    Biochem Biophys Res Commun; 2015 Feb; 458(1):123-7. PubMed ID: 25637537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression.
    Fang S; Huang SF; Cao J; Wen YA; Zhang LP; Ren GS
    Clin Exp Med; 2013 May; 13(2):127-34. PubMed ID: 22543497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
    Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
    EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.
    Chen XH; Wu WG; Ding J
    Tumour Biol; 2014 Feb; 35(2):967-71. PubMed ID: 24006221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
    Ni X; Lin Z; Dai S; Chen H; Chen J; Zheng C; Wu B; Ao J; Shi K; Sun H
    J Cell Biochem; 2020 Jul; 121(7):3626-3641. PubMed ID: 32065423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
    Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
    Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma.
    Song G; Zhu X; Xuan Z; Zhao L; Dong H; Chen J; Li Z; Song W; Jin C; Zhou M; Xie H; Zheng S; Song P
    Theranostics; 2021; 11(5):2318-2333. PubMed ID: 33500727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
    Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
    J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.
    Qiu GH; Xie H; Wheelhouse N; Harrison D; Chen GG; Salto-Tellez M; Lai P; Ross JA; Hooi SC
    J Hepatol; 2007 Apr; 46(4):655-63. PubMed ID: 17258345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.